Skip to main content

Choice and Timing of Antithrombotic after Ischemic Stroke, Intracerebral Hemorrhage or Cerebral Venous Thrombosis.

Publication ,  Journal Article
Ryan, D; Girotra, T; Feng, W
Published in: CNS Neurol Disord Drug Targets
2024

Stroke is a multifactorial vascular disease and remains a leading cause of disability in the United States. Strokes can be ischemic or hemorrhagic in nature and secondary to arterial or venous disease, making determining the etiology and secondary prevention strategy important for preservation of the injured brain, prevention of recurrent strokes, and in the maintenance of good functional outcomes for patients impacted by stroke. In this narrative review, we provide a synopsis of the available medical evidence surround selection, timing, and choice of therapy, including utilization of left atrial appendage closure, in patients with ischemic, hemorrhagic or venous stroke.

Duke Scholars

Published In

CNS Neurol Disord Drug Targets

DOI

EISSN

1996-3181

Publication Date

2024

Volume

23

Issue

2

Start / End Page

135 / 152

Location

United Arab Emirates

Related Subject Headings

  • Neurology & Neurosurgery
  • 3214 Pharmacology and pharmaceutical sciences
  • 3209 Neurosciences
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ryan, D., Girotra, T., & Feng, W. (2024). Choice and Timing of Antithrombotic after Ischemic Stroke, Intracerebral Hemorrhage or Cerebral Venous Thrombosis. CNS Neurol Disord Drug Targets, 23(2), 135–152. https://doi.org/10.2174/1871527322666230309100626
Ryan, Dylan, Tarun Girotra, and Wuwei Feng. “Choice and Timing of Antithrombotic after Ischemic Stroke, Intracerebral Hemorrhage or Cerebral Venous Thrombosis.CNS Neurol Disord Drug Targets 23, no. 2 (2024): 135–52. https://doi.org/10.2174/1871527322666230309100626.
Ryan D, Girotra T, Feng W. Choice and Timing of Antithrombotic after Ischemic Stroke, Intracerebral Hemorrhage or Cerebral Venous Thrombosis. CNS Neurol Disord Drug Targets. 2024;23(2):135–52.
Ryan, Dylan, et al. “Choice and Timing of Antithrombotic after Ischemic Stroke, Intracerebral Hemorrhage or Cerebral Venous Thrombosis.CNS Neurol Disord Drug Targets, vol. 23, no. 2, 2024, pp. 135–52. Pubmed, doi:10.2174/1871527322666230309100626.
Ryan D, Girotra T, Feng W. Choice and Timing of Antithrombotic after Ischemic Stroke, Intracerebral Hemorrhage or Cerebral Venous Thrombosis. CNS Neurol Disord Drug Targets. 2024;23(2):135–152.

Published In

CNS Neurol Disord Drug Targets

DOI

EISSN

1996-3181

Publication Date

2024

Volume

23

Issue

2

Start / End Page

135 / 152

Location

United Arab Emirates

Related Subject Headings

  • Neurology & Neurosurgery
  • 3214 Pharmacology and pharmaceutical sciences
  • 3209 Neurosciences
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1109 Neurosciences